Biotech Growth N V - Nov 1, 2024 Form 4 Insider Report for ESSA Pharma Inc. (EPIX)

Role
10%+ Owner
Signature
By: /s/Martin Gubler
Stock symbol
EPIX
Transactions as of
Nov 1, 2024
Transactions value $
-$12,018,409
Form type
4
Date filed
11/5/2024, 12:06 PM
Previous filing
Oct 19, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction EPIX Common Shares Sale -$3.06M -2M -25.38% $1.53 5.88M Nov 1, 2024 Direct
transaction EPIX Common Shares Sale -$3.05M -2M -34.02% $1.53 3.88M Nov 1, 2024 Direct
transaction EPIX Common Shares Sale -$3.06M -2M -51.55% $1.53 1.88M Nov 1, 2024 Direct
transaction EPIX Common Shares Sale -$2.84M -1.88M -100% $1.51 0 Nov 1, 2024 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Biotech Growth N V is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may continue.

Remarks:

Biotech Growth N.V. is a wholly-owned subsidiary of BB Biotech AG. Accordingly, BB Biotech AG may be deemed to be the indirect beneficial owner of the securities of ESSA Pharma Inc. held directly or indirectly by Biotech Growth N.V. This Form 4 is filed jointly by BB Biotech AG and Biotech Growth N.V.